Acetylmuramyl-Alanyl-Isoglutamine
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Acetylmuramyl-Alanyl-Isoglutamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.
    
			
			
				
				
					
						| Descriptor ID | D000119 | 
					
						| MeSH Number(s) | D09.067.550.050 D09.811.522.050 D12.644.233.050 | 
					
						| Concept/Terms | Acetylmuramyl-Alanyl-IsoglutamineAcetylmuramyl-Alanyl-IsoglutamineMuramyl DipeptideDipeptide, MuramylAcetylmuramyl Alanyl IsoglutamineAlanyl Isoglutamine, AcetylmuramylIsoglutamine, Acetylmuramyl Alanyl
 Mur-NAc-L-Ala-D-isoGlnMur-NAc-L-Ala-D-isoGlnMur NAc L Ala D isoGlnN-Acetylmuramyl-L-Alanyl-D-IsoglutamineN Acetylmuramyl L Alanyl D IsoglutamineN-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-AmideN Acetyl Muramyl L Alanyl D Glutamic alpha Amide
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Acetylmuramyl-Alanyl-Isoglutamine".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Acetylmuramyl-Alanyl-Isoglutamine".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Acetylmuramyl-Alanyl-Isoglutamine" by people in this website by year, and whether "Acetylmuramyl-Alanyl-Isoglutamine" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2000 | 1 | 0 | 1 | 
| 2005 | 0 | 1 | 1 | 
| 2007 | 1 | 0 | 1 | 
| 2009 | 1 | 1 | 2 | 
| 2010 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Acetylmuramyl-Alanyl-Isoglutamine" by people in Profiles.
						
					
								- 
								Charri?re GM, Ip WE, Dejardin S, Boyer L, Sokolovska A, Cappillino MP, Cherayil BJ, Podolsky DK, Kobayashi KS, Silverman N, Lacy-Hulbert A, Stuart LM. Identification of Drosophila Yin and PEPT2 as evolutionarily conserved phagosome-associated muramyl dipeptide transporters. J Biol Chem. 2010 Jun 25; 285(26):20147-54. 
- 
								Coulombe F, Divangahi M, Veyrier F, de L?s?leuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med. 2009 Aug 03; 206(8):1709-16. 
- 
								Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA, Fitzgerald KA, Sassetti CM, Kelliher MA. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 2009 Jul; 5(7):e1000500. 
- 
								Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem. 2007 Dec 14; 282(50):36223-9. 
- 
								Butler JE, Francis DH, Freeling J, Weber P, Krieg AM. Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens. J Immunol. 2005 Nov 15; 175(10):6772-85. 
- 
								Yoshimura A, Takada H, Kaneko T, Kato I, Golenbock D, Hara Y. Structural requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-kappaB activation in CHO cells. J Endotoxin Res. 2000; 6(5):407-10. 
- 
								Miller-Graziano CL, Kodys K, Gonzalez F, Fudem GM. Continued tumor necrosis factor receptor expression by trauma patients' monocytes (Mphi) despite TNF alpha secretion. Shock. 1994 May; 1(5):317-24.